nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—CYP2D6—Parkinson's disease	0.852	1	CbGaD
Labetalol—Isoprenaline—ADRBK1—Parkinson's disease	0.00238	0.185	CrCbGaD
Labetalol—Lisdexamfetamine—SLC18A2—Parkinson's disease	0.00226	0.176	CrCbGaD
Labetalol—Ifenprodil—GRIN2B—Parkinson's disease	0.00169	0.131	CrCbGaD
Labetalol—Dobutamine—COMT—Parkinson's disease	0.00149	0.116	CrCbGaD
Labetalol—Benazepril—MTHFR—Parkinson's disease	0.000991	0.0773	CrCbGaD
Labetalol—Lisdexamfetamine—SLC6A3—Parkinson's disease	0.000937	0.0731	CrCbGaD
Labetalol—Mirabegron—CYP2D6—Parkinson's disease	0.000671	0.0523	CrCbGaD
Labetalol—Formoterol—CYP2D6—Parkinson's disease	0.000537	0.0418	CrCbGaD
Labetalol—Arformoterol—CYP2D6—Parkinson's disease	0.000537	0.0418	CrCbGaD
Labetalol—Mirabegron—ABCB1—Parkinson's disease	0.000479	0.0374	CrCbGaD
Labetalol—Tolterodine—CYP2D6—Parkinson's disease	0.000353	0.0275	CrCbGaD
Labetalol—Propafenone—CYP2D6—Parkinson's disease	0.0003	0.0234	CrCbGaD
Labetalol—Propafenone—ABCB1—Parkinson's disease	0.000214	0.0167	CrCbGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000211	0.00156	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—GRM5—Parkinson's disease	0.000206	0.00153	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000204	0.00151	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000203	0.0015	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000202	0.0015	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—EDN1—Parkinson's disease	0.0002	0.00149	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000199	0.00148	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000198	0.00147	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000195	0.00145	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000195	0.00145	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000193	0.00143	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000191	0.00141	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000191	0.00141	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000186	0.00138	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000182	0.00135	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RIT2—Parkinson's disease	0.000177	0.00131	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000176	0.0013	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HTR2A—Parkinson's disease	0.000175	0.0013	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000175	0.0013	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	0.000173	0.00128	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000172	0.00127	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	0.00017	0.00126	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.000169	0.00125	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	0.000169	0.00125	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GRK5—Parkinson's disease	0.000168	0.00125	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000167	0.00124	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000167	0.00124	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.000166	0.00123	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.000165	0.00123	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—TAC1—Parkinson's disease	0.000165	0.00122	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.000164	0.00122	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000163	0.00121	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000161	0.0012	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000161	0.00119	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.000161	0.00119	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000159	0.00118	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.000159	0.00118	CbGpPWpGaD
Labetalol—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000159	0.00118	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.000158	0.00117	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000156	0.00116	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000156	0.00116	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000156	0.00116	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.000155	0.00115	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.000155	0.00115	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000153	0.00113	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR1A—Parkinson's disease	0.000152	0.00113	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.000152	0.00112	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GRM4—Parkinson's disease	0.000151	0.00112	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—TAC1—Parkinson's disease	0.00015	0.00111	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.000149	0.0011	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.000149	0.0011	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.000148	0.0011	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD1—Parkinson's disease	0.000147	0.00109	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000146	0.00108	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.000145	0.00108	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.000145	0.00108	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000145	0.00107	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.000144	0.00106	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PENK—Parkinson's disease	0.000143	0.00106	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAG—Parkinson's disease	0.000143	0.00106	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD3—Parkinson's disease	0.000142	0.00105	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000142	0.00105	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000141	0.00105	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000141	0.00105	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.000141	0.00104	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000137	0.00101	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000135	0.000997	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000134	0.000991	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000133	0.00099	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000133	0.000985	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000133	0.000983	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000133	0.000983	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.000132	0.000976	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.000132	0.000976	CbGpPWpGaD
Labetalol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000132	0.000976	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000132	0.000975	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.000131	0.000974	CbGpPWpGaD
Labetalol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000131	0.000971	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PDYN—Parkinson's disease	0.000131	0.000969	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.000129	0.000955	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.000129	0.000955	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.000129	0.000953	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR7—Parkinson's disease	0.000128	0.000952	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD2—Parkinson's disease	0.000128	0.000952	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GFAP—Parkinson's disease	0.000123	0.000911	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.000122	0.000905	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000122	0.000905	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GRM5—Parkinson's disease	0.000122	0.000901	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00012	0.000893	CbGpPWpGaD
Labetalol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00012	0.000893	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.000119	0.000886	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.000119	0.000882	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000118	0.000873	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000116	0.000862	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000114	0.000848	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000113	0.000839	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000112	0.000829	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FGF20—Parkinson's disease	0.000107	0.00079	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	0.000105	0.00078	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000104	0.000771	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000104	0.00077	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000103	0.000766	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	0.000103	0.000763	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—EDN1—Parkinson's disease	0.000103	0.000762	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000102	0.000754	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000102	0.000753	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	9.98e-05	0.00074	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	9.92e-05	0.000736	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HTR2A—Parkinson's disease	9.91e-05	0.000734	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	9.77e-05	0.000724	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	9.76e-05	0.000724	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	9.71e-05	0.00072	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	9.58e-05	0.00071	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	9.56e-05	0.000709	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—INSR—Parkinson's disease	9.54e-05	0.000707	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	9.38e-05	0.000695	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	9.28e-05	0.000688	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	9.08e-05	0.000673	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FGB—Parkinson's disease	9.02e-05	0.000668	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	9.01e-05	0.000668	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR2A—Parkinson's disease	9e-05	0.000667	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR1A—Parkinson's disease	8.97e-05	0.000665	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	8.95e-05	0.000664	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	8.88e-05	0.000658	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TAC1—Parkinson's disease	8.83e-05	0.000655	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	8.82e-05	0.000653	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	8.76e-05	0.000649	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	8.7e-05	0.000645	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	8.68e-05	0.000644	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.67e-05	0.000643	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD1—Parkinson's disease	8.66e-05	0.000642	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ND3—Parkinson's disease	8.66e-05	0.000642	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.66e-05	0.000642	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	8.51e-05	0.000631	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	8.49e-05	0.000629	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	8.49e-05	0.000629	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.48e-05	0.000629	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	8.43e-05	0.000625	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	8.39e-05	0.000622	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	8.39e-05	0.000622	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD3—Parkinson's disease	8.39e-05	0.000622	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	8.3e-05	0.000615	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	8.3e-05	0.000615	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	8.25e-05	0.000611	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	8.21e-05	0.000609	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	8.21e-05	0.000609	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	8.14e-05	0.000603	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—OMD—Parkinson's disease	8.14e-05	0.000603	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.87e-05	0.000583	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRBK1—Parkinson's disease	7.83e-05	0.000581	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	7.76e-05	0.000575	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.72e-05	0.000572	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	7.7e-05	0.000571	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	7.62e-05	0.000565	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	7.62e-05	0.000565	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	7.59e-05	0.000563	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR7—Parkinson's disease	7.59e-05	0.000562	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD2—Parkinson's disease	7.59e-05	0.000562	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	7.46e-05	0.000553	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	7.46e-05	0.000553	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCH1—Parkinson's disease	7.36e-05	0.000546	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	7.3e-05	0.000541	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	7.22e-05	0.000535	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	7.14e-05	0.000529	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	7.06e-05	0.000523	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	6.72e-05	0.000498	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	6.57e-05	0.000487	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GBA—Parkinson's disease	6.56e-05	0.000486	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DBH—Parkinson's disease	6.56e-05	0.000486	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.56e-05	0.000486	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF2—Parkinson's disease	6.36e-05	0.000471	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	6.33e-05	0.000469	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	6.19e-05	0.000459	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1R—Parkinson's disease	6.15e-05	0.000456	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	6.14e-05	0.000455	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	6.1e-05	0.000452	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EDN1—Parkinson's disease	6.07e-05	0.00045	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	6e-05	0.000445	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	5.97e-05	0.000443	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.88e-05	0.000436	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	5.75e-05	0.000426	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	5.66e-05	0.00042	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NGF—Parkinson's disease	5.58e-05	0.000414	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	5.54e-05	0.000411	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	5.35e-05	0.000397	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	5.34e-05	0.000396	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	5.32e-05	0.000395	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR2A—Parkinson's disease	5.31e-05	0.000394	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	5.24e-05	0.000389	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	5.23e-05	0.000388	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	5.22e-05	0.000387	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	5.21e-05	0.000386	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	5.14e-05	0.000381	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	5.13e-05	0.00038	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	5.03e-05	0.000373	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	4.98e-05	0.000369	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOE—Parkinson's disease	4.94e-05	0.000366	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	4.87e-05	0.000361	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DDC—Parkinson's disease	4.82e-05	0.000357	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	4.65e-05	0.000345	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	4.55e-05	0.000337	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.55e-05	0.000337	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	4.5e-05	0.000334	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	4.5e-05	0.000334	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	4.41e-05	0.000327	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	4.41e-05	0.000327	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—INS—Parkinson's disease	4.22e-05	0.000313	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	4.09e-05	0.000304	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MAOB—Parkinson's disease	4.05e-05	0.0003	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	3.77e-05	0.00028	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	3.69e-05	0.000274	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	3.65e-05	0.00027	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	3.61e-05	0.000267	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	3.57e-05	0.000265	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	3.53e-05	0.000261	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	3.31e-05	0.000246	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	3.24e-05	0.00024	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	3.15e-05	0.000234	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CASP3—Parkinson's disease	3.14e-05	0.000233	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—Parkinson's disease	3.12e-05	0.000231	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	3.09e-05	0.000229	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.96e-05	0.000219	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.93e-05	0.000217	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK8—Parkinson's disease	2.89e-05	0.000214	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2.87e-05	0.000213	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.75e-05	0.000204	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.72e-05	0.000202	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TH—Parkinson's disease	2.68e-05	0.000199	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.58e-05	0.000191	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.5e-05	0.000186	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—INS—Parkinson's disease	2.45e-05	0.000182	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—COMT—Parkinson's disease	2.28e-05	0.000169	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.27e-05	0.000168	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.27e-05	0.000168	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.24e-05	0.000166	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.15e-05	0.000159	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.09e-05	0.000155	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX1—Parkinson's disease	2e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.86e-05	0.000138	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.85e-05	0.000137	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.85e-05	0.000137	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—Parkinson's disease	1.84e-05	0.000137	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.82e-05	0.000135	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.81e-05	0.000134	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.72e-05	0.000127	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.71e-05	0.000127	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.68e-05	0.000124	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—INS—Parkinson's disease	1.47e-05	0.000109	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.09e-05	8.11e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	1.07e-05	7.94e-05	CbGpPWpGaD
